Phần Lan -
Tiếng Phần Lan -
Fimea (Suomen lääkevirasto)
agomelatine stada 25 mg tabletti, kalvopäällysteinen
stada arzneimittel ag - agomelatine citric acid cocrystal - tabletti, kalvopäällysteinen - 25 mg - agomelatiini
Phần Lan -
Tiếng Phần Lan -
Fimea (Suomen lääkevirasto)
agomelatine anpharm 25 mg tabletti, kalvopäällysteinen
anpharm przedsiebiorstwo farmaceutyczne s.a. - agomelatine - tabletti, kalvopäällysteinen - 25 mg - agomelatiini
Liên Minh Châu Âu -
Tiếng Phần Lan -
EMA (European Medicines Agency)
dovprela (previously pretomanid fgk)
mylan ire healthcare limited - pretomanid - tuberkuloosi, monilääkeresistenssi - mykobakteerilÄÄkkeet - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). on otettava huomioon viralliset ohjeet antibioottien tarkoituksenmukaisesta käytöstä.
Liên Minh Châu Âu -
Tiếng Phần Lan -
EMA (European Medicines Agency)
skysona
bluebird bio (netherlands) b.v. - elivaldogene autotemcel - adrenoleukodystrophy - muut hermoston huumeet - treatment of early cerebral adrenoleukodystrophy in patients less than 18 years of age, with an abcd1 genetic mutation, and for whom a human leukocyte antigen (hla) matched sibling haematopoietic stem cell donor is not available.
Liên Minh Châu Âu -
Tiếng Phần Lan -
EMA (European Medicines Agency)
rybrevant
janssen-cilag international n.v. - amivantamab - karsinooma, ei-pienisoluinen keuhko - antineoplastiset aineet - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.
Liên Minh Châu Âu -
Tiếng Phần Lan -
EMA (European Medicines Agency)
tepmetko
merck europe b.v. - tepotinib hydrochloride monohydrate - karsinooma, ei-pienisoluinen keuhko - antineoplastiset aineet - tepmetko as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum-based chemotherapy.
Phần Lan -
Tiếng Phần Lan -
Fimea (Suomen lääkevirasto)
rativor 2.5 mg tabletti
macure healthcare limited - lorazepam - tabletti - 2.5 mg - loratsepaami
Phần Lan -
Tiếng Phần Lan -
Fimea (Suomen lääkevirasto)
rativor 1 mg tabletti
macure healthcare limited - lorazepam - tabletti - 1 mg - loratsepaami
Phần Lan -
Tiếng Phần Lan -
Fimea (Suomen lääkevirasto)
rativor 0.5 mg tabletti
macure healthcare limited - lorazepam - tabletti - 0.5 mg - loratsepaami
Liên Minh Châu Âu -
Tiếng Phần Lan -
EMA (European Medicines Agency)
akeega
janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - eturauhasen kasvaimet, kastraatio-resistentin - antineoplastiset aineet - treatment of adult patients with prostate cancer.